MoonLake Immunotherapeutics
MLTX
#5970
Rank
NZ$1.71 B
Marketcap
NZ$24.16
Share price
-9.06%
Change (1 day)
-75.29%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -NZ$0.37 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.22 Billion a decrease over its 2023 earnings that were of -NZ$93.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.37 Billion69.16%
2024 -NZ$0.22 Billion129.45%
2023 -NZ$93.76 Million-16.81%
2022 -NZ$0.12 Billion